Autism patients report improvement in symptoms and quality of life with Zelira Therapeutics’ HOPE

Written by Erica Daniels

Self-reported outcomes survey of 50 participants using Zelira Therapeutics’ HOPE formulations for symptoms associated with Autism Spectrum Disorder (ASD)

Erica Daniels https://ericadaniels.com
Next

Cannabis Business Times: Ohio Bill Would Add Autism as Qualifying Medical Cannabis Condition